Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Chubb
Teva
Cantor Fitzgerald
US Department of Justice
AstraZeneca
Colorcon
Merck
Medtronic
Fuji

Generated: May 28, 2018

DrugPatentWatch Database Preview

ELIXICON Drug Profile

or, see our see our flat-rate plans

« Back to Dashboard

When do Elixicon patents expire, and when can generic versions of Elixicon launch?

Elixicon is a drug marketed by Forest Labs and is included in one NDA.

The generic ingredient in ELIXICON is theophylline. There are thirty-six drug master file entries for this compound. Twenty-six suppliers are listed for this compound. Additional details are available on the theophylline profile page.
Summary for ELIXICON
US Patents:0
Applicants:1
NDAs:1
Bulk Api Vendors: 98
Formulation / Manufacturing:see details
DailyMed Link:ELIXICON at DailyMed
Drug patent expirations by year for ELIXICON

US Patents and Regulatory Information for ELIXICON

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Forest Labs ELIXICON theophylline SUSPENSION;ORAL 085502-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

or, see our see our flat-rate plans

or, see our see our flat-rate plans

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Fish and Richardson
Moodys
Mallinckrodt
Fuji
US Department of Justice
Covington
US Army
Cerilliant
Accenture

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.